Safety and Efficacy Study of Oral Zabofloxacin in Community Acquired Pneumonia

NCT01081964 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

48

Enrollment

INDUSTRY

Sponsor class

Stopped Financial considerations

Conditions

Community Acquired Pneumonia

Interventions

DRUG: Zabofloxacin
DRUG: Levofloxacin 500mg
DRUG: Zabofloxacin 400mg

Sponsor

IASO Pharma Inc.